Testing Status of Diethanolamine 10534-A
CASRN: 111-42-2
Formula: C4-H11-N-O2
Synonyms/Common Names
- DEA
- 2,2'-Iminobisethanol
Short-Term Toxicity
- 2 weeks (Topical Application)
(C55174B)
Completed
- TOX-20 (NIH Number: 92-3343)
(Peer Review Approval 11/21/1991A )
Toxicity Studies of Diethanolamine (CASRN 111-42-2) Administered Topically and in Drinking Water to F344/N Rats and B6C3F1 Mice - Rats: F344/N; Mice: B6C3F1
- Dose: R: 0, 125, 250, 500, 1000, AND 2000 MG/KG; M: 0, 160, 320, 630, 1250, and 2500 mg/kg/ 5D/WK.
- TOX-20 (NIH Number: 92-3343)
(Peer Review Approval 11/21/1991A )
- 2 weeks (Dosed-Water)
(C55174C)
Completed
- TOX-20 (NIH Number: 92-3343)
(Peer Review Approval 11/21/1991A )
Toxicity Studies of Diethanolamine (CASRN 111-42-2) Administered Topically and in Drinking Water to F344/N Rats and B6C3F1 Mice - Rats: F344/N; Mice: B6C3F1
- Dose: R&M: 0, 630, 1250, 2500, 5000, 10000 PPM.
- TOX-20 (NIH Number: 92-3343)
(Peer Review Approval 11/21/1991A )
- 13 weeks (Topical Application)
(C55174B)
Completed
- TOX-20 (NIH Number: 92-3343)
Toxicity Studies of Diethanolamine (CASRN 111-42-2) Administered Topically and in Drinking Water to F344/N Rats and B6C3F1 Mice - Rats: F344/N; Mice: B6C3F1
- Dose: R: 0, 32, 63, 125, 250, 500 MG/KG; M: 0, 80, 160, 320, 630, OR 1250 MG/KG.
- TOX-20 (NIH Number: 92-3343)
- 13 weeks (Dosed-Water)
(C55174C)
Completed
- TOX-20 (NIH Number: 92-3343)
Toxicity Studies of Diethanolamine (CASRN 111-42-2) Administered Topically and in Drinking Water to F344/N Rats and B6C3F1 Mice - Rats: F344/N; Mice: B6C3F1
- Dose: MR: 0, 320, 630, 1250, 2500, OR 5000 PPM; FR: 0, 160, 320, 630, 1250, OR 2500 PPM; M: 0, 630, 1250, 2500, 5000, OR 10000 PPM.
- TOX-20 (NIH Number: 92-3343)
Long-Term Carcinogenicity
- 2 years (Topical Application)
(C55174D)
Completed
- TR-478 (NIH Number: 99-3968)
(Peer Review Approval 12/10/1997A )
Toxicology and Carcinogenesis Studies of Diethanolamine in F344/N Rats and B6C3F1 Mice (Dermal Studies) - Rats: F344/N; Mice: B6C3F1
- Carcinogenesis Results
- Male Rats No Evidence
- Female Rats No Evidence
- Male Mice Clear Evidence
- Female Mice Clear Evidence
- Dose: MR: 0, 16, 32, OR 64 MG/KG; FR: 0, 8, 16, OR 32 MG/KG; MICE: 0, 40, 80, OR 160 MG/KG (50/SEX/SPECIES/GROUP).
- TR-478 (NIH Number: 99-3968)
(Peer Review Approval 12/10/1997A )
Special Studies
- Absorption Distribution Metabolism Excretion (Gavage; Topical Application; Intravenous; Gavage; Topical Application; Intravenous)
(S0145)
Completed
- Citation: Mathews JM, Garner CE, Matthews HB. Metabolism, bioaccumulation, and incorporation of diethanolamine into phospholipids. Chem Res Toxicol. 1995 Jul-Aug;8(5):625-33.Pubmed Abstract
- Male Rats: F344/N; Male Mice: B6C3F1
- Absorption Distribution Metabolism Excretion (Gavage)
(S0813)
Completed
- Rats; Mice
- Absorption Distribution Metabolism Excretion (Dosed-Feed)
(S0814)
Completed
- Rats; Mice
Genetic Toxicology
- In Vitro Cytogenetics (CA/SCE)
(095123)
Completed
- Citation: Loveday, K.S., Lugo, M.H., Resnick, M.A., Anderson, B., and Zeiger, E. Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro II: Results with 20 chemicals Environ. Molec. Mutagen. Vol. 13 (1989) 60-94
- Sister Chromatid Exchange Negative
- Chromosome Aberrations Negative
- Micronucleus
(A08796)
Completed
- Citation: Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194
- Mice: B6C3F1
- Male Negative
- Female Negative
- Mouse Lymphoma
(375254)
Completed
- Mice
- Negative
- Salmonella
(310797)
Completed
- Citation: Haworth, S., Lawlor, T., Mortelmans, K., Speck, W., and Zeiger, E. Salmonella mutagenicity test results for 250 chemicals Environ. Mutagen. Vol. 5 (Suppl 1) (1983) 3-142
- Negative
Organ Systems Toxicity
- 6 to 19 GD Conventional Teratology (Gavage)
(TER96001)
Completed
- Female Rats: Sprague Dawley
- Dose: 0, 50, 125, 200, 250, OR 300 MG/KG/DAY.
- 14 days Immunotoxicity (Gavage)
(IMM20004)
Completed
- Female Mice: B6C3F1
- Dose: 0, 100, 300, 400, 500, 600, 700, 800, 900, 1000, 1250, OR 1500 MG/KG.
- 14 days Immunotoxicity (Gavage)
(IMM20303)
Completed
- Female Rats: F344/N
- Dose: 0, 50 100, OR 200 MG/KG.
- 14 days Immunotoxicity (Gavage)
(IMM98011)
Completed
- Female Mice: B6C3F1
- Dose: 0, 100, 300, OR 600 MG/KG (STUDIES 1-11 AND 13); 0, 300, 600, OR 800 MG/KG (STUDY 12).
- 30 days Neurotoxicology Assessment (Gavage)
(NTA20101)
Completed
- Male and Female Rats: Sprague Dawley
- Dose: 0, 6.67, 20, OR 60 MG/KG.
- 8 to 15 GD (copulatory plug=0 GD) Short-Term in vivo Repro. Tox. (Gavage)
(T0074)
Completed
- Female Mice: Swiss
- 6 to 15 GD Teratology Pilot Studies (Gavage)
(TRP90012)
Completed
- Female Rats: Sprague Dawley
- Dose: 0, 50, 200, 500, 800, OR 1200 MG/KG.